Chieftain Securities
Home OUR BUSINESS The Team THE HQ NEWS PORTFOLIO CHATTER CONTACT
HomeOUR BUSINESSThe TeamTHE HQNEWSPORTFOLIOCHATTERCONTACT
Chieftain Securities
PYC - RP11 Clinical Trial - Dosing Completed in Cohort 3
Harriet Meagan28 February 20242024
Facebook0 Twitter 0 Likes
Previous

STX - 1HFY24 Results and Operational Update

Harriet Meagan28 February 20242024
Next

STX - Talon Acquisition Implemented

Harriet Meagan27 December 20232023
Chieftain Securities
1202 Hay Street,
West Perth, WA, 6005,
Australia
info@chiefsec.com.au
Hours

Copyright © 2021 Chieftain Securities | All Right Reserved | Images used with Permission. Privacy Policy